PROCEPT BioRobotics (PRCT) Cash from Operations (QoQ) (2021 - 2026)
Analysis
PROCEPT BioRobotics (PRCT) Cash from Operations (QoQ) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn |
| 10 | PROCEPT BioRobotics | 1.17 Bn | 895.36 Mn | 62.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49.51% |
| Mar 31, 2026 | -269.20% |
| Dec 31, 2025 | -55.64% |
| Sep 30, 2025 | 55.89% |
| Jun 30, 2025 | 11.41% |
| Mar 31, 2025 | 47.58% |
| Dec 31, 2024 | -72.29% |
| Sep 30, 2024 | -19.47% |
| Jun 30, 2024 | 51.26% |
| Mar 31, 2024 | -30.22% |
| Dec 31, 2023 | -30.88% |
| Sep 30, 2023 | 33.16% |
| Jun 30, 2023 | 21.12% |
| Mar 31, 2023 | -42.72% |
| Dec 31, 2022 | -26.81% |
| Sep 30, 2022 | -15.91% |
| Jun 30, 2022 | 6.06% |
| Mar 31, 2022 | -10.65% |
| Dec 31, 2021 | -29.21% |
| Sep 30, 2021 | 1.22% |